Loading…
DCM Shriram Fine Chemicals (DSFCL)₹27.24−0.91%Specialty Chemicals
In the Jun 2026 quarter (consolidated), DCM Shriram Fine Chemicals reported sales of ₹90.85 Cr, down 7.9% from Jun 2025, and net profit of ₹2.60 Cr, down 39.8% year on year. For the year to Mar 2026, sales were ₹386 Cr and net profit −₹4.01 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 93.41 | 113 | 98.67 | 96.98 | 97.05 | 93.18 | 90.85 |
| Expenses | 88.55 | 106 | 91.41 | 98.47 | 96.62 | 95.67 | 85.72 |
| Operating Profit | 4.86 | 7.61 | 7.30 | −1.48 | 0.31 | −2.50 | 5.08 |
| OPM % | 5.2% | 6.7% | 7.4% | −1.6% | 0.3% | −2.7% | 5.6% |
| Other Income | 0.98 | 1.02 | 0.95 | 0.69 | 0.82 | 0.75 | 1.05 |
| Interest | 0.40 | 0.49 | 0.29 | 0.21 | 0.23 | 0.68 | 0.43 |
| Depreciation | 2.21 | 2.17 | 2.17 | 2.18 | 2.12 | 2.07 | 1.96 |
| Profit before tax | 3.27 | 5.99 | 5.81 | −3.21 | −1.23 | −4.53 | 3.78 |
| Tax % | 26.7% | 26.0% | 25.6% | −21.0% | 22.1% | −15.3% | 31.0% |
| Net Profit | 2.40 | 4.43 | 4.32 | −2.54 | −1.50 | −3.84 | 2.60 |
| EPS (Rs) | 0.23 | 0.43 | 0.42 | −0.24 | −0.16 | −0.43 | 0.29 |
| Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|
| Sales | 429 | 386 | 378 |
| Expenses | 396 | 379 | 376 |
| Operating Profit | 32.91 | 6.98 | 1.41 |
| OPM % | 7.9% | 1.8% | 0.4% |
| Other Income | 4.01 | 0.00 | 3.31 |
| Interest | 1.99 | 0.99 | 1.55 |
| Depreciation | 9.02 | 8.01 | 8.33 |
| Profit before tax | 26.06 | −3.01 | −5.19 |
| Tax % | 26.0% | 13.0% | — |
| Exceptional items | 0.00 | −3.01 | — |
| Net Profit | 19.03 | −4.01 | −5.28 |
| EPS (Rs) | 1.91 | −0.40 | −0.54 |
| Dividend payout % | 0.0% | 0.0% | — |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 0.00 | 17.00 |
| Reserves | 215 | 194 |
| Borrowings | 12.97 | 12.98 |
| Other Liabilities | 79.62 | 71.65 |
| Total Liabilities | 307 | 295 |
| Fixed Assets | 130 | 103 |
| CWIP | 0.00 | 0.00 |
| Investments | 22.95 | 32.93 |
| Other Assets | 155 | 159 |
| Inventories | 50.17 | 41.16 |
| Trade receivables | 83.26 | 70.21 |
| Cash & equivalents | 14.95 | 36.92 |
| Total Assets | 307 | 295 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from operating activity | 14.95 | 15.93 |
| Cash from investing activity | 0.00 | 10.99 |
| Cash from financing activity | −15.02 | −6.01 |
| Net cash flow | 0.00 | 20.98 |
| Capex | 2.54 | 1.63 |
| Free cash flow | 11.99 | 34.99 |
| CFO / OP % | 73.0% | 294.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor days | 69 | 66 |
| Inventory days | 75 | 65 |
| Days payable | 81 | 79 |
| Cash conversion cycle | 65 | 53 |
| Working capital days | 53 | 47 |
| ROCE % | — | 1.0% |
For the Jun 2026 quarter, DCM Shriram Fine Chemicals reported sales of ₹90.85 Cr, down 7.9% year on year and net profit of ₹2.60 Cr, down 39.8% year on year. The operating margin was 5.6%.
DCM Shriram Fine Chemicals' sales for the year to Mar 2026 were ₹386 Cr; over the last twelve months they were ₹378 Cr.
Net profit for the year to Mar 2026 was −₹4.01 Cr, and −₹5.28 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.54.
DCM Shriram Fine Chemicals reported borrowings of ₹12.98 Cr at Mar 2026, against cash and equivalents of ₹36.92 Cr.
Cash from operations was ₹15.93 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹34.99 Cr.